NUPAM MAHAJAN
Inventor
Stats
- 0 US patents issued
- 4 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 0 US Patents Issued
- 4 US Applications Filed
- 0 Total Citation Count
- May 20, 2024 Most Recent Filing
- Nov 10, 2015 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. | 1
| 2015
|
UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. | 1
| 2015
|
Inventor Addresses
Address | Duration |
---|---|
Clayton, MO, US | Oct 07, 21 - Sep 19, 24 |
St. Louis, MO, US | Jan 14, 25 - Jan 14, 25 |
Tampa, FL, US | Nov 23, 17 - May 19, 20 |
Technology Profile
Technology | Matters | |
---|---|---|
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 1 |
A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 1 |
C07D: | HETEROCYCLIC COMPOUNDS | 2 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
12194057 | 2025 | NXTAR-derived oligonucleotides and uses thereof | 0 |
2024/0308,971 | 2024 | ALLOSTERIC INHIBITOR OF WEE1 KINASE | 0 |
11987568 | 2024 | Allosteric inhibitor of WEE1 kinase | 0 |
2021/0309,630 | 2021 | ALLOSTERIC INHIBITOR OF WEE1 KINASE | 0 |
10655185 | 2020 | Methods for diagnosis and prognosis of epithelial tumors | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.